Drug Recalls - Los Angeles Jury Awards $48 Million to Man Using Motrin

Drug Articles

Home

Latest Drug News

News Blog

Los Angeles Jury Awards $48 Million to Man Using Motrin

Wednesday, 05 October 2011 13:07 | Written by Drug Recall Lawyer |

A Los Angeles Superior Court jury in California awarded $48 million to a man who allegedly contracted a severe skin disorder and mouth blisters after taking the popular pain reliever Motrin. The man filed a negligence lawsuit against the drug manufacturer, claiming that his side effects were not adequately listed on the medication label. The man said that after using Motrin to get rid of aches and alleviate a fever, he noticed skin lesions and mouth blisters. The manufacturer has claimed that the side effects and conditions could be connected to aspirin and Tylenol.

Have You Been Injured?

Free Claim Review
If you or a loved one have suffered a serious injury or side effect related to drug or supplement, please contact us for a free and confidential case review.

Name:

Email:

Address:

City:

State:

Zip Code:

Day Phone:

Evening Phone:

Have you been injured or experienced side-effects due to a drug or supplement?:

Yes
No

Name of Drug(s) or Supplement(s):

Date(s) of Drug / Supplement Use:

Date(s) of Injury or Diagnosis Related to Drug / Supplement Use:

Please describe problem or injury:

Enter the code you see in the box:

Polls

Do You Think The FDA Is Doing Enough To Protect Consumers?

	Yes
	No
	Don't Know

Drug Recalls, Copyright © 2001 - 2011. All Rights Reserved.
DrugRecalls.com - Drug Recalls provides information about U.S. Food and Drug Administration drug recall, warning, and safety issues involving prescription drugs, over-the-counter drugs, dietary supplements. Drug Recalls is a legal newsletter. Our attorneys provide legal advice on drug recalls, drug alerts, drug warnings, and practice law in federal courts across the United States and in jurisdictions or states where licensed to practice.
Sponsored by attorney Dana Taschner. 1-800-448-5800
Please Read our Terms Of Use